COMMUNIQUÉS West-GlobeNewswire

Intra-Cellular Therapies Continues to Strengthen Its Commercial Leadership Team; John A. Bardi Appointed as Senior Vice President, Market Access, Policy and Government Affairs
26/03/2019
NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
InspireMD Announces 1-for-50 Reverse Stock Split
26/03/2019
TEL AVIV, Israel, March 26, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, [...]
Arvinas Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update
26/03/2019
Recently Announced the Initiation of Patient Dosing in the First Phase 1 Clinical Trial with a Targeted PROTAC™ Protein Degrader ARV-110 NEW HAVEN, Conn., March 26, 2019 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN [...]
Cronos Group Inc. Announces Fourth Quarter 2018 and Full Year 2018 Results
26/03/2019
Closed C$2.4 Billion Strategic Growth Investment from Altria Group, Inc. Completed first harvest in Peace Naturals expansion to Building 4 Launched Two Recreational Brands: COVE™ and Spinach™ Announced Landmark [...]
Teleflex Publishes Inaugural Corporate Social Responsibility (CSR) Report
26/03/2019
The report highlights how employees are driving the company mission into their communities, what the company and employees are doing to help protect the environment and how the company is achieving high standards for [...]
BriaCell to Announce Early Efficacy Data of Lead Candidate in Combination with KEYTRUDA® at AACR Annual Meeting
26/03/2019
Early data of BriaCell’s combination study of lead candidate, Bria-IMT™, with KEYTRUDA ® (by Merck & Co., Inc.) in advanced breast cancer will be announced at the American Association for Cancer Research (AACR) [...]
BrainStorm Announces Grant of an additional New European Patent for NurOwn®
26/03/2019
NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- BrainStorm Cell Therapeutics Inc. ( NASDAQ: BCLI ), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced that the European [...]
CampDoc and Waldo Photos Announce New Partnership for Facial Recognition Photo Sharing with Parents
26/03/2019
ANN ARBOR, Mich., March 26, 2019 (GLOBE NEWSWIRE) -- CampDoc, the leading electronic health record system for camps , is excited to announce a new partnership with Waldo Photos , an Austin-based startup that uses facial [...]
Bhang Corporation’s Scott Van Rixel and Jamie Pearson Named to High Times' Most Influential People in Cannabis
26/03/2019
LOS ANGELES, March 26, 2019 (GLOBE NEWSWIRE) -- Bhang Corporation ("Bhang" or the "Company"), the global cannabis house of brands with an extensive, award-winning portfolio of products, is proud to announce that Bhang [...]
American Addiction Centers: Fentanyl Presence Rising in Client Testing
26/03/2019
Testing Data and Monitoring of DEA Seizure Reports Reveals Need to Expand and Refine Screening Criteria to Detect Dangerous Street Drugs that Impact Intake, Care BRENTWOOD, Tenn., March 26, 2019 (GLOBE NEWSWIRE) -- With [...]
Autolus Therapeutics Unveils Expanded Next Generation Technology and Pipeline and Provides Key Update on AUTO3 Program in Pediatric ALL at R&D Day
26/03/2019
Program and webcast – today, March 26, 2019 at 8:00 am ET LONDON, March 26, 2019 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical company developing next generation [...]
Zomedica Pharmaceuticals Corp. Announces Pricing of $3 Million Underwritten Public Offering of Common Shares
26/03/2019
ANN ARBOR, Mich., March 26, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or the “Company”), a veterinary diagnostic and pharmaceutical company, today announced [...]
LIDDS: NanoZolid® technology receives US patent valid until 2037
26/03/2019
The United States Patent and Trademark Office has issued a Notice of Allowance for the NanoZolid ® technology patent. This will provide additional patent protection for all LIDDS development projects. The same patent [...]
Notice of Annual General Meeting in Immunicum AB (publ)
26/03/2019
Press Release 26 March 2019 Notice of Annual General Meeting in Immunicum AB (publ) The shareholders of Immunicum AB (publ) (the "Company"), reg. no 556629-1786, are hereby invited to the Annual General Meeting on [...]
Wildflower Brands Inc. (CSE : SUN) (OTCQB : WLDFF) en vedette dans la publication NetworkNewsWire sur l'industrie du CBD à base de chanvre en forte progression
26/03/2019
NEW YORK, 26 mars 2019 (GLOBE NEWSWIRE) -- via NetworkWire – NetworkNewsWire (« NNW »), société d’information financière et d’édition à multiples facettes, annonce aujourd’hui la publication d’un éditorial présentant [...]
CFO of Oasmia, Anders Blom has resigned
26/03/2019
Yesterday Oasmia received the resignation of the Company’s CFO Anders Blom. The Board and the CEO have decided to appoint, as acting CFO, Joakim Lindén. Joakim Lindén has long experience from transition processes in [...]
Curetis and Menarini Diagnostics Enter into Strategic Pan-European Exclusive Partnership for the Distribution of Curetis’ Unyvero
26/03/2019
Menarini Diagnostics to distribute Unyvero Platform and application cartridges in numerous European countries Menarini Diagnostics to deploy its commercial team for the marketing of Unyvero Platform across Europe [...]
Verona Pharma to Present at H.C. Wainwright Global Life Sciences Conference
26/03/2019
LONDON, March 26, 2019 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM: VRP) (NASDAQ: VRNA) (“Verona Pharma”), a clinical stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Nanobiotix announces its clinical registration plan in Head and Neck cancers for the United States following FDA feedback
26/03/2019
Moving forward with Overall Survival (OS)-based, randomized, event-driven clinical trial for the United States Pre-IND feedback from US Food and Drug Administration (FDA) provides clarity to Nanobiotix on US regulatory [...]

Pages